Showing results (171-180 of 3,348) with videos related to

Sort By:
Pageof 335
Pharmacoeconomics|January 20, 2023
Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic EvaluationsCarina M Behr, Martijn J Oude Wolcherink, Maarten J IJzerman, et al.
Pharmacoeconomics|July 1, 2021
Utility Values Associated with Atypical Hemolytic Uremic Syndrome-Related Attributes: A Discrete Choice Experiment in Five CountriesKate Williams, Daniel Aggio, Peter Chen, et al.
Pharmacoeconomics|July 17, 2021
Lifetime Costs for Treated Follicular Lymphoma Patients in the USCaitlin Eichten, Qiufei Ma, Thomas E Delea, et al.
Pharmacoeconomics|May 13, 2022
Addressing Challenges to Alternative Payment Models for New Alzheimer's Disease Therapies for US Commercial PayersJakub P Hlávka, Tara A Lavelle, Peter J Neumann, et al.
Pharmacoeconomics|July 15, 2021
Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic ReviewSimon van der Pol, Paula Rojas Garcia, Maarten J Postma, et al.
Pharmacoeconomics|May 3, 2023
How Much Better is Faster? Value Adjustments for Health-Improvement SequencesF Reed Johnson, Juan Marcos Gonzalez, John J Sheehan, et al.
Pharmacoeconomics|November 5, 2003
Evaluating minimal clinically important differences for the acne-specific quality of life questionnaireLori D McLeod, Sheri E Fehnel, Jane Brandman, et al.
Pharmacoeconomics|November 5, 2003
Indirect costs in ambulatory patients with HIV/AIDS in Spain: a pilot studyJuan Oliva, César Roa, Juan del Llano
Pharmacoeconomics|May 20, 2003
Quality of life and economic considerations in the management of prostate cancerMarco Turini, Alberto Redaelli, Paola Gramegna, et al.
Pharmacoeconomics|August 12, 2003
Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczemaCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.
Pageof 335